To compare the short-term and long-term outcomes of laparoscopic versus open surgery for low rectal cancer.
Methods:
Patients with low rectal cancer who underwent laparoscopic or open surgery at our department from January 2009 to December 2013 were enrolled in this retrospective study. The primary end points were 3-year local recurrence and overall and disease-free survival (DFS) rates. Secondary end points were intraoperative and postoperative outcomes.
Results:
Laparoscopic group had longer operative time (165.0 versus 140.0, P < .001), less blood loss (20.0 versus 40.0, P < .001), shorter length of incision (5.0 versus 18.0, P < .001), and more lymph node harvested (11.0 versus 9.0, P = .002). However, time to first flatus (P = .941), postoperative hospital stay (P = .095), postoperative complications (P = .155), and 30-day mortality (P = .683) was similar between two groups. With the median follow-up period of 65 months, the 3-year local recurrence rate was 4.3% in laparoscopic group and 7.5% in open group (P = .077); the 3-year overall and DFS rates were similar in two groups (85.9% versus 88.8%, P = .229 and 76.9% versus 79.2%, P = .448, respectively); and the overall and DFS curves were comparable between two groups (hazard ratio [HR] = 0.858, 95% confidence intervals [CI] 0.709–1.037, P = .112 and HR = 1.076, 95% CI 0.834–1.389, P = .275, respectively).
Conclusions:
Laparoscopic surgery is safe and has equivalent long-term oncologic outcomes for low rectal cancer when compared to open surgery. Furthermore, large-scale, prospective randomized clinical trials are needed to confirm the present findings.
LacyAM, Garcia-ValdecasasJC, DelgadoS, et al.Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: A randomised trial. Lancet, 2002; 359:2224–2229.
3.
FleshmanJ, SargentDJ, GreenE, et al.Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg, 2007; 246:655–662; discussion 662–654.
4.
VeldkampR, KuhryE, HopWC, et al.Laparoscopic surgery versus open surgery for colon cancer: Short-term outcomes of a randomised trial. Lancet Oncol, 2005; 6:477–484.
5.
NelsonH, SargentDJ, WieandHS, et al.A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med, 2004; 350:2050–2059.
6.
GuillouPJ, QuirkeP, ThorpeH, et al.Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): Multicentre, randomised controlled trial. Lancet, 2005; 365:1718–1726.
7.
LacyAM, Garcia-ValdecasasJC, PiqueJM, et al.Short-term outcome analysis of a randomized study comparing laparoscopic vs open colectomy for colon cancer. Surg Endosc, 1995; 9:1101–1105.
8.
BuunenM, VeldkampR, HopWC, et al.Survival after laparoscopic surgery versus open surgery for colon cancer: Long-term outcome of a randomised clinical trial. Lancet Oncol, 2009; 10:44–52.
9.
LacyAM, DelgadoS, CastellsA, et al.The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg, 2008; 248:1–7.
10.
SchwenkW, HaaseO, NeudeckerJ, MullerJM. Short term benefits for laparoscopic colorectal resection. Cochrane Database Syst Rev, 2005; Cd003145.
11.
KuhryE, SchwenkWF, GaupsetR, et al.Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev, 2008; Cd003432.
12.
JayneDG, ThorpeHC, CopelandJ, et al.Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg, 2010; 97:1638–1645.
13.
van der PasMH, HaglindE, CuestaMA, et al.Laparoscopic versus open surgery for rectal cancer (COLOR II): Short-term outcomes of a randomised, phase 3 trial. Lancet Oncol, 2013; 14:210–218.
14.
BonjerHJ, DeijenCL, AbisGA, et al.A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med, 2015; 372:1324–1332.
15.
JeongSY, ParkJW, NamBH, et al.Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): Survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol, 2014; 15:767–774.
16.
KangSB, ParkJW, JeongSY, et al.Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): Short-term outcomes of an open-label randomised controlled trial. Lancet Oncol, 2010; 11:637–645.
17.
StevensonAR, SolomonMJ, LumleyJW, et al.Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: The ALaCaRT Randomized Clinical Trial. JAMA, 2015; 314:1356–1363.
18.
FleshmanJ, BrandaM, SargentDJ, et al.Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: The ACOSOG Z6051 randomized clinical trial. JAMA, 2015; 314:1346–1355.
19.
WuQB, WangM, HuT, et al.Prognostic role of the lymphocyte-to-monocyte ratio in patients undergoing resection for nonmetastatic rectal cancer. Medicine (Baltimore), 2016; 95:e4945.
20.
HealdRJ, MoranBJ, RyallRD, et al.Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg, 1998; 133:894–899.
21.
WeiserMR, MilsomJW. Laparoscopic total mesorectal excision with autonomic nerve preservation. Semin Surg Oncol, 2000; 19:396–403.
22.
LaurentC, LeblancF, WutrichP, et al.Laparoscopic versus open surgery for rectal cancer: long-term oncologic results. Ann Surg, 2009; 250:54–61.
23.
MorinoM, PariniU, GiraudoG, et al.Laparoscopic total mesorectal excision: A consecutive series of 100 patients. Ann Surg, 2003; 237:335–342.
24.
DindoD, DemartinesN, ClavienPA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004; 240:205–213.
25.
WangYW, HuangLY, SongCL, et al.Laparoscopic vs open abdominoperineal resection in the multimodality management of low rectal cancers. World J Gastroenterol, 2015; 21:10174–10183.
26.
OdermattM, FlashmanK, KhanJ, ParvaizA. Laparoscopic-assisted abdominoperineal resection for low rectal cancer provides a shorter length of hospital stay while not affecting the recurrence or survival: A propensity score-matched analysis. Surg Today, 2016; 46:798–806.
27.
WangZ, ZhangXM, LiangJW, et al.Evaluation of short-term outcomes after laparoscopically assisted abdominoperineal resection for low rectal cancer. ANZ J Surg, 2014; 84:842–846.
28.
NgSS, LeungKL, LeeJF, et al.RCT laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: A prospective randomized trial. Ann Surg Oncol, 2008; 15:2418–2425.
29.
ZhouZG, HuM, LiY, et al.Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc, 2004; 18:1211–1215.
30.
KapiteijnE, MarijnenCA, NagtegaalID, et al.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 2001; 345:638–646.
31.
GerardJP, ConroyT, BonnetainF, et al.Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol, 2006; 24:4620–4625.
32.
SauerR, BeckerH, HohenbergerW, et al.Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004; 351:1731–1740.
33.
LawWL, LeeYM, ChoiHK, et al.Laparoscopic and open anterior resection for upper and mid rectal cancer: An evaluation of outcomes. Dis Colon Rectum, 2006; 49:1108–1115.
34.
LelongB, BegeT, EsterniB, et al.Short-term outcome after laparoscopic or open restorative mesorectal excision for rectal cancer: A comparative cohort study. Dis Colon Rectum, 2007; 50:176–183.
35.
RickertA, HerrleF, DoyonF, et al.Influence of conversion on the perioperative and oncologic outcomes of laparoscopic resection for rectal cancer compared with primarily open resection. Surg Endosc, 2013; 27:4675–4683.
36.
YamamotoS, FukunagaM, MiyajimaN, et al.Impact of conversion on surgical outcomes after laparoscopic operation for rectal carcinoma: A retrospective study of 1,073 patients. J Am Coll Surg, 2009; 208:383–389.
37.
VennixS, PelzersL, BouvyN, et al.Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev, 2014; Cd005200.
38.
BoschSL, NagtegaalID. The importance of the pathologist's role in assessment of the quality of the mesorectum. Curr Colorectal Cancer Rep, 2012; 8:90–98.
